VCA
DGX icon

Verdence Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Verdence Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Hold
1,131
– – 0.01% 596
2026
Q1 		$222K Buy
+1,131
New +$220K 0.01% 584
2025
Q4 		– Sell
-1,141
Closed -$206K – 672
2025
Q3 		$206K Buy
+1,141
New +$202K 0.01% 666
2024
Q1 		– Sell
-5,223
Closed -$720K – 592
2023
Q4 		$720K Buy
5,223
+161
+3% +$21.2K 0.07% 272
2023
Q3 		$617K Buy
5,062
+502
+11% +$66.9K 0.07% 287
2023
Q2 		$641K Sell
4,560
-494
-10% -$68.1K 0.07% 269
2023
Q1 		$715K Sell
5,054
-1,058
-17% -$151K 0.09% 243
2022
Q4 		$956K Sell
6,112
-1,320
-18% -$190K 0.12% 179
2022
Q3 		$912K Sell
7,432
-863
-10% -$114K 0.13% 181
2022
Q2 		$1.1M Sell
8,295
-618
-7% -$84.2K 0.14% 164
2022
Q1 		$1.22M Buy
8,913
+4,153
+87% +$579K 0.14% 163
2021
Q4 		$824K Buy
4,760
+2,756
+138% +$419K 0.1% 202
2021
Q3 		$291K Buy
+2,004
New +$293K 0.04% 389

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Verdence Capital Advisors's DGX Position: Q2 2026 in Review

Verdence Capital Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,131 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #596.

Verdence Capital Advisors first reported a position in DGX in Q3 2021 and has held it in 13 quarters since. The position peaked at $1.22M in Q1 2022. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Verdence Capital Advisors held 1,131 shares of Quest Diagnostics worth $240K as of Q2 2026.
  • Verdence Capital Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Verdence Capital Advisors's portfolio in Q2 2026, its #596 holding.
  • Verdence Capital Advisors first reported a position in Quest Diagnostics in Q3 2021 and has held it in 13 quarters since.
  • Verdence Capital Advisors's Quest Diagnostics position peaked at $1.22M in Q1 2022.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.